VistaGen Therapeutics
VTGN
VTGN
83 hedge funds and large institutions have $4.79M invested in VistaGen Therapeutics in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 85 → 83 (-2)
Holders
83
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$117K | |
| 2 | +$33.6K | |
| 3 | +$26.5K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26K |
| 5 |
HNWA
Henrickson Nauta Wealth Advisors
Belmont,
Michigan
|
+$24.9K |
Top Sellers
| 1 | -$597K | |
| 2 | -$476K | |
| 3 | -$41.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$26.4K |
| 5 |
Millennium Management
New York
|
-$11K |